Member Info for cj62

DTW well said but the sp languishing still makes me question my investment. We have the HCI shares shortly which will pressurise the sp further .

My major annoyance is not having spare cash to buy more as the Taxman is presently more pressing

Thornogson

Could you please answer this question, have adc's proven to be better than any previous treatments?

We dream of being 100 % up but still only 220 Hurst

AS stated its the start, if the sp is still around this price next year we've been had.

We need cohort 7 completed and fortnightly started to make any difference

There needs to be something relayed on completion of cohort 7 , full data hopefully or the important bits.

The quarterly share dump is due in 2 weeks I would like something prior as the sp will be under pressure again.

So with all the data from cohorts 5&6 and now on 7 with a 2 week dosing regime starting the SP is down 5 % from 12 months ago.

We aren't seeing something or the market is as they say thick as frozen mince.

Ice if patients from cohort 5 are still receiving ava 6k at the start of April that will be 12 months since 1st dose. If cohort 4 are still receiving ava 6k that is at least 16 months. PFS by all intent and purpose is 6 months ( FDA ) avacta are way past that , I personally would love to see this specific data.

JT. Shouldn't information/ data that may have a affect on the sp be released ?

I realise there are many reasons not to but they should rns completion with a basic outline of data. They are just getting on with it I know but for how long no one knows.

I am being patient although I keep asking what is everyone missing or am I not seeing something.

As stated in the 13-12 rns

Cohort 7, the final cohort in the three-weekly dose escalation safety study of AVA6000, has completed enrolment and is ongoing.

So if the cohort goes to plan we may see some data by the end of Feb or am I being a little optimistic?

RD I have always thought the affimer had mileage but let's put that on the back burner for the moment and concentrate on commercialisation of AVA6 k

Yes Michbens.

ES. I think if someone bid 2-3 bill a lot of PIs would jump at the chance , a lot of cash has been tied up for a long time now.

Ceesor that is what a BP partner will be for

Thompi the sp was 145 2 years ago

TDF we have a proven platform I am expecting more than £2 .

Hopefully not but if avacta have managed to fully hold on to ava 6k and it works unequivocally then the share price will reflect that with a TO price of goodness knows how much.

Personally I want it to hang on but would like to see the value curve forming upwards sharply

And by the way TB must rank as the most corrupt politian of our era.

Just the mention of Tony Blair makes my skin crawl.

I suppose the fees were quite substantial at the time but with a lot more data and it actually works should make a tremendous difference to any licence deals forthcoming

PL I expect a few deals and as you say 10's of millions but if they partner with ava 6k I expect huge future milestone payments.

The more deals the greater the validation but I would prefer a serious up lift in the sp over the next 12 months as we all aren't on £500k a year while tinkering with his test tubes